The tumor-intrinsic role of the m 6 A reader YTHDF2 in regulating immune evasion

Sai Xiao,Shoubao Ma,Baofa Sun,Wenchen Pu,Songqi Duan,Jingjing Han,Yaqun Hong,Jianying Zhang,Yong Peng,Chuan He,Ping Yi,Michael A. Caligiuri,Jianhua Yu

DOI: https://doi.org/10.1126/sciimmunol.adl2171

IF: 30.63

2024-06-01

Science Immunology

Abstract:Tumors evade attacks from the immune system through various mechanisms. Here, we identify a component of tumor immune evasion mediated by YTH domain–containing family protein 2 (YTHDF2), a reader protein that usually destabilizes m 6 A-modified mRNA. Loss of tumoral YTHDF2 inhibits tumor growth and prolongs survival in immunocompetent tumor models. Mechanistically, tumoral YTHDF2 deficiency promotes the recruitment of macrophages via CX3CL1 and enhances mitochondrial respiration of CD8 + T cells by impairing tumor glycolysis metabolism. Tumoral YTHDF2 deficiency promotes inflammatory macrophage polarization and antigen presentation in the presence of IFN-γ. In addition, IFN-γ induces autophagic degradation of tumoral YTHDF2, thereby sensitizing tumor cells to CD8 + T cell–mediated cytotoxicity. Last, we identified a small molecule compound that preferentially induces YTHDF2 degradation, which shows a potent antitumor effect alone but a better effect when combined with anti–PD-L1 or anti–PD-1 antibodies. Collectively, YTHDF2 appears to be a tumor-intrinsic regulator that orchestrates immune evasion, representing a promising target for enhancing cancer immunotherapy.

immunology

What problem does this paper attempt to address?

The paper aims to explore the role of YTHDF2 (an m6A reader protein) in tumor immune evasion and proposes its potential as a target to enhance cancer immunotherapy.

Specifically, the paper addresses the following key issues:
1. **The relationship between YTHDF2 and immune evasion**: The study found that YTHDF2 in tumor cells promotes immune evasion by regulating the expression of CX3CL1, which limits the recruitment and polarization of macrophages.
2. **The impact of YTHDF2 deficiency**: Through gene knockout experiments, researchers observed that the absence of YTHDF2 can inhibit tumor growth and extend the survival of mice, and this effect is mainly dependent on the action of CD8+ T cells.
3. **Remodeling the tumor microenvironment**: The deficiency of YTHDF2 not only increases the proportion of anti-tumor macrophages but also promotes the recruitment of effector CD8+ T cells, thereby remodeling the tumor microenvironment to be more immunoreactive.
4. **Molecular mechanism**: Further research indicates that YTHDF2 affects the expression level of CX3CL1 by regulating the stability of CX3CL1 mRNA, which in turn influences the recruitment of macrophages.
5. **Application of small molecule compounds**: Finally, the researchers identified a small molecule compound that can specifically induce the degradation of YTHDF2. This compound has an anti-cancer effect when used alone and shows better efficacy when combined with anti-PD-L1 or anti-PD-1 antibodies.

In summary, the paper reveals the important role of YTHDF2 in tumor immune evasion and proposes a new strategy to enhance cancer immunotherapy by targeting YTHDF2.